The Jordanian Pharmaceutical Manufacturing Co. PLC Stock Forecast for 2022 - 2025 - 2030
Updated on 09/27/2022
The Jordanian Pharmaceutical Manufacturing Co. PLC Fair Value Forecast for 2022 - 2025 - 2030
In the last three years, The Jordanian Pharmaceutical Manufacturing Co. PLC's Price has grown by 100.00%, rising from 0.00 to 0.00. For the next year, analysts predict that Fair Value will reach 0.00 – an increase of 100.00%. Over the next nine years, experts believe that The Jordanian Pharmaceutical Manufacturing Co. PLC's Fair Value will grow at a rate of 100.00%.
The Jordanian Pharmaceutical Manufacturing Co. PLC Revenue Forecast for 2022 - 2025 - 2030
In the last year, The Jordanian Pharmaceutical Manufacturing Co. PLC's Revenue has decreased from 22.21M to 9.98M – a 55.07% drop. For the next year, analysts predict that Revenue will reach 22.21M – an increase of 122.55%. Over the next eleven years, experts believe that The Jordanian Pharmaceutical Manufacturing Co. PLC's Revenue will grow at a rate of 5223.89%.
.jpg)
The Jordanian Pharmaceutical Manufacturing Co. PLC Free Cash Flow Forecast for 2022 - 2025 - 2030
The Jordanian Pharmaceutical Manufacturing Co. PLC's Free Cash Flow has decreased by 15.97% In the last year, from -2.38M to -2.00M. In the next year, analysts believe that Free Cash Flow will reach -2.38M – an increase of 19.00%. For the next eleven years, the forecast is forFree Cash Flow to grow by 14.20%.
The Jordanian Pharmaceutical Manufacturing Co. PLC Net Income Forecast for 2022 - 2025 - 2030
In the last year, The Jordanian Pharmaceutical Manufacturing Co. PLC's Net Income has seen an increase, rising from -4.10M to -5.86M. This represents a growth of 42.93%. For the following year, the 0 analysts predict that The Jordanian Pharmaceutical Manufacturing Co. PLC's Net Income will drop by 30.03%, reaching -4.10M. In 2030, the professionals' prediction is that JPHM's Net Income will decrease by 16.25%, reaching -4.91M.
The Jordanian Pharmaceutical Manufacturing Co. PLC EBITDA Forecast for 2022 - 2025 - 2030
In the last year, The Jordanian Pharmaceutical Manufacturing Co. PLC's EBITDA has decreased from 1.37M to -5.87M – a 528.47% drop! In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach -13.11M – an increase of 123.34%. Over the next eleven years, experts anticipate that EBITDA growth for The Jordanian Pharmaceutical Manufacturing Co. PLC will be 135.99%.
The Jordanian Pharmaceutical Manufacturing Co. PLC EBIT Forecast for 2022 - 2025 - 2030
In the last year, The Jordanian Pharmaceutical Manufacturing Co. PLC has seen a decline in its EBIT, from 780.00k to -6.29M – a 906.41% decrease. In the next year, analysts predict that EBIT will reach -13.36M – an increase of 112.40%. For the next eleven years, the forecast is for EBIT to grow by 119.42%.
The Jordanian Pharmaceutical Manufacturing Co. PLC EPS Price Prediction Forecast for 2022 - 2025 - 2030
In the last three years, The Jordanian Pharmaceutical Manufacturing Co. PLC's EPS has grown by 525.00%, rising from -0.04 to -0.25. For the next year, analysts predict that EPS will reach -0.55 – an increase of 119.00%. Over the next nine years, experts believe that The Jordanian Pharmaceutical Manufacturing Co. PLC's EPS will grow at a rate of 210.37%.
Site Navigation
.jpg)